Minimal clinically important difference in the Hip disability and Osteoarthritis Outcome Score (HOOS) for patients undergoing total hip arthroplasty: A multicenter prospective cohort study
Journal of Orthopaedic Surgery · 2026-01 · 34 (1)
DOI: 10.1177/10225536261433423 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Orthopaedic Surgery, online erschienen am 02.04.2026. Verfasst von Junji Nishimoto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Faculty of Health Sciences, Tokyo Kasei Univeristy, Sayama City, Saitama, Japan. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Osteoarthritis, Hip, Minimal Clinically Important Difference, Disability Evaluation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Total hip arthroplasty (THA) is an effective treatment for hip osteoarthritis (OA), improving pain, function, and quality of life (QOL). The Hip disability and Osteoarthritis Outcome Score (HOOS) is widely used to assess treatment outcomes; however, the minimal clinically important difference (MCID) in the short-term remains unclear. This study aimed to determine MCID values for HOOS at 3 and 6 months post-THA using the anchor method.
Methods
This multicenter prospective cohort study included patients with hip OA undergoing primary unilateral THA. HOOS subscales (symptoms, pain, activities of daily living [ADL], sport and recreation [SR], and QOL) were assessed preoperatively and at 3 and 6 months postoperatively. MCID was determined using receiver operating characteristic analyses with the Global Rating of Change scale as the anchor.
Results
A total of 127 patients were included in the analysis, with 107 patients assessed at 3 months and 102 at 6 months post-THA. At 3 months after THA, the MCID values for the HOOS subscales were 7.50 for symptoms, 8.75 for pain, 4.41 for ADL, 9.38 for SR, and 9.38 for QOL. At 6 months after THA, the corresponding MCID values were 12.50, 11.25, 23.53, 10.00, and 15.63, respectively.
Conclusion
Short-term MCID values for HOOS subscales post-THA were established, aiding early assessment of treatment effectiveness and guiding postoperative care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation, Faculty of Health Sciences, Tokyo Kasei Univeristy, Sayama City, Saitama, Japan.
- Department of Rehabilitation, Saitama Medical Center, Saitama Medical University, Kawagoe City, Saitama, Japan.
- Department of Physical Therapy, Faculty of Health and Medical Science, Teikyo Heisei University, Toshima-ku, Tokyo, Japan.
- Graduate School of Humanities and Social Sciences, Hiroshima University, Higashi-Hiroshima City, Hiroshima, Japan.
ORCID-Profile: Junji Nishimoto
Zitieren
APA
Nishimoto, J., Kurahashi, R., Tamari, K., & Tanaka, R. (2026). Minimal clinically important difference in the Hip disability and Osteoarthritis Outcome Score (HOOS) for patients undergoing total hip arthroplasty: A multicenter prospective cohort study. Journal of Orthopaedic Surgery, 34(1). https://doi.org/10.1177/10225536261433423
Vancouver
Nishimoto J, Kurahashi R, Tamari K, Tanaka R. Minimal clinically important difference in the Hip disability and Osteoarthritis Outcome Score (HOOS) for patients undergoing total hip arthroplasty: A multicenter prospective cohort study. Journal of Orthopaedic Surgery. 2026;34(1). doi:10.1177/10225536261433423
BibTeX
@article{Nishimoto2026,
author = {Nishimoto, Junji and Kurahashi, Rikumi and Tamari, Kotaro and Tanaka, Ryo},
title = {Minimal clinically important difference in the Hip disability and Osteoarthritis Outcome Score (HOOS) for patients undergoing total hip arthroplasty: A multicenter prospective cohort study},
journal = {Journal of Orthopaedic Surgery},
year = {2026},
volume = {34},
number = {1},
doi = {10.1177/10225536261433423}
}
EUVIMED